Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Convalescent Immune Plasma Therapy in Severe COVID-19 Patients With Acute Respiratory Distress Syndrome

NCT04442958 is registered in ClinicalTrials.gov with Bagcilar Training and Research Hospital as lead sponsor.

NCT NCT04442958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04442958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Convalescent Immune Plasma Therapy in Severe COVID-19 Patients With Acute Respiratory Distress Syndrome
Lead sponsor
Bagcilar Training and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 15, 2020
Completion date
June 17, 2020
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome